Endocrine characterization of a human ovarian carcinoma (BG-1) established in nude mice

Steroids

Volumn 54, Issue 6, 1989, Pages 593-606

  Zimniski, Stephen J ^a   Garola, Roberto E ^b   Fendl, Karin ^a   Peterson, C Matthew ^c  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN; AROMATASE INHIBITOR; ESTRADIOL; GONADORELIN AGONIST; STEROID RECEPTOR;

ARTICLE; HORMONAL REGULATION; HUMAN; MOUSE; NONHUMAN; OVARY CANCER; TUMOR GROWTH;

ANIMAL; CYTOSOL; FEMALE; HORMONES; HUMAN; MALE; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; OVARIAN NEOPLASMS; OVARIECTOMY; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

MUS MUSCULUS; MUS;

EID: 0024804713     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0039-128X(89)90083-4     Document Type: Article

References (49)

1. Heterotransplantation of human malignant tumors in “nude” thymusless mice. II. Malignant tumors induced by infection of cell cultures derived from human solid tumors
2. Transplantation of human tumors in nude mice
3. Clonal variation of MCF-7 breast cancer cells in vitro and in athymic nude mice
4. Effect of 17β-oestradiol on growth curves and flow cytometric DNA distribution of two human breast carcinomas grown in nude mice
5. Role of hormones in the growth and regression of human breast cancer cells (MCF-7) transplanted into athymic nude mice
6. Hormone dependency of a serially transplanted human breast cancer (Br-10) in nude mice
7. Estrogen responsive proliferation of clonal human breast carcinoma cells in athymic mice
8. Required presence of both estrogen and pituitary factors for the growth of human breast cancer cells in athymic nude mice
9. Hormonal therapy of human endometrial adenocarcinoma in nude mouse model
10. Endocrine sensitivity of the receptor-positive T-61 human breast carcinoma serially grown in nude mice
11. Dose-dependent effect of 17β-estradiol determined by growth curves and flow cytometric DNA analysis of a human breast carcinoma (T-61) growth in nude mice
12. Growth inhibition by progestins in a human endometrial cancer cells line with estrogen-independent progesterone receptors
13. 1 phase of the cell cycle
14. 1 phase
15. Effects of the antiestrogen tamoxifen on the cell cycle kinetics of the human breast cancer cell line, MCF07
16. Effects of tamoxifen on the receptor-positive T61 and the receptor-negative T60 human breast carcinomas grown in nude mice
17. Effects of estrogens and antiestrogens on human breast cancer cell proliferation : In vitro studies in tissue culture and in vivo studies in athymic mice
18. 2 and cytotoxic agents studied in a clonogenic assay
19. Effect of the antiestrogen C1628 in the growth of rat mammary tumors
20. Ovarian cancer (review)
21. Multiple parameter analysis of human ovarian cancer: Morphology, immunohistochemistry, steroid hormone receptors and aromatase
22. Androgen receptor predominance in human ovarian carcinoma
23. Steroid receptors in a human ovarian carcinoma established in nude mice
24. Characterizations of a human ovarian carcinoma cell line with estrogen and progesterone receptors
25. Characterization of a human ovarian carcinoma cell line (NIH: OVCAR-3) with androgen and estrogen receptors
26. Comparison of four new cell lines from patients with adenocarcinoma of the ovary
27. The occurrence of multiple steroid hormone receptors in disease-free and neoplastic human ovary
28. Correlation of aromatase activity and steroid receptors in human ovarian carcinoma
29. Estrogen receptors and prognosis of breast cancer
30. Estrogen control of progesterone receptor in human breast cancer
31. MCF-7: A human breast cancer cell line with estrogen, androgen, progesterone, and glucocorticoid receptors
32. Aromatase activity in human ovarian cancer
33. Comparative studies of aromatase inhibitors in cultured human breast cancer cells
34. Steroid hormones: Biosynthesis, secretion and transport
35. Diethylstilbestrol Recommended dosages for different categories of breast cancer patients
36. The effect of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term culture
37. The effects of 17β-estradiol on progesterone secretion by bovine theca and granulosa cells
38. Luteinizing hormone releasing hormone analogs in control of fertility and gonadal hormone dependent disease
39. Absence of gonadotropin-releasing hormone receptor in human gonadal tissue
40. Absence of specific luteinizing hormone releasing hormone receptors in ovine, bovine and porcine ovaries
41. Gonadotropin-releasing hormone (GnRH)-binding sites in human breast cancer cell lines and inhibitory effects of GnRH antagonists
42. Receptors for prolactin somatostatin and luteinizing hormone-releasing hormone in experimental prostate cancer after treatment with analogs of luteinizing hormone-releasing hormone and somatostatin
43. Direct inhibitory effect of luteinizing hormone-releasing hormone agonist on MCF-7 human breast cancer cells
44. Gonadotropin-releasing hormone agonists are unsuccessful in reducing tumoral gonadotropin secretion in two patients with gonadotropin-secreting pituitary adenomas
45. Effects of aromatase inhibitors, aminoglutethimide and 4-hydroxyandrostenedione on cyclic rats and rats with 7,12-dimethylbenz(a)anthracene-induced mammary tumors
46. Treatment of advanced postmenopausal breast cancer with an aromatase inhibitor, 4-hydroxyandrostenedione: Phase II report
47. Response to D-Trp-6-luteinizing hormone releasing hormone (Decapeptyl) microcapsules in advanced ovarian cancer
48. Clinical management of advanced prostatic cancer
49. Use of analogs of LH-RH and somatostatin for the treatment of hormone dependent cancers